.svg)
Retatrutide - Stronger than Ozempic, Beyond Wegovy
Discover the next generation of weight loss treatment - more effective, longer-lasting, and designed for real results.
Better Overall Health
Less Cravings, Less Struggle
Boost Your Sex Life
Sustainable Weight Loss
%201.webp)
.webp)
How it works
Innovation that transforms your weight and health
Reduces Appetite Naturally
Retatrutide signals your brain to feel full faster, helping you eat less comfortably each day.
Boosts Metabolic Health
Retatrutide supports better blood sugar control and enhances metabolism for steady weight loss.
Supports Lasting Results
By combining appetite and metabolic benefits, Retatrutide helps maintain long-term weight loss.
.webp)
Nearly a Quarter of Body Weight Lost in Under a Year
"It is remarkable that participants with obesity who received Retatrutide lost nearly a quarter of their body weight over 11 months of treatment. These results underscore Retatrutide's significant potential as a therapy that can meaningfully support weight loss in individuals with obesity."
%
Average body weight reduction after treatment.
x
Stronger appetite control than other options.
/10
Patients report improved health and energy.
days
First visible results appear within two weeks.
.webp)
Achieve Your Best Body with Retatrutide
Experience a breakthrough in weight management with Retatrutide, reducing hunger, improving vitality, and showing visible results in weeks.
Reviewing the leading treatments for obesity management
Semaglutide started the movement. Tirzepatide raised the bar. Now, Retatrutide is redefining what’s possible — delivering weight loss results no other treatment has achieved.
(Reta)
(Ozempic)
(Wegovy)
Register your interest in Retatrutide
Retatrutide is currently not available, but once it is approved, you’ll be the first to get notified. Sign up now and stay informed.
Simple one-time sign-up
Early access to availability updates
Exclusive status among the first users
Advantage over non-registered users
Weight Loss Insights
Evidence-based articles to support your journey toward sustainable health.
Answers to Popular Questions
If you have any specific questions, feel free to reach out.
Retatrutide is a new experimental medication from the GLP-1/GIP/Glucagon agonist class, developed for the treatment of obesity and type 2 diabetes. It works by reducing appetite, slowing stomach emptying, and affecting hormones that regulate metabolism and body weight.
Retatrutide is intended for people with obesity or overweight, as well as those with type 2 diabetes. It is not yet officially approved and is currently available only in clinical trials.
In studies, participants lost about 25% of their body weight over 48 to 72 weeks of treatment. Results depend on the dosage and individual response.
Retatrutide is primarily being developed for obesity, but it also benefits people with type 2 diabetes by regulating blood sugar.
Initial weight loss results are usually noticeable after 4–8 weeks. The most significant weight reduction typically occurs within the first 12–18 months of treatment.
As with other GLP-1 drugs, some weight regain is possible after discontinuation. Long-term therapy combined with lifestyle changes is recommended.
Early results suggest it is safe, but further research is needed. It is not yet available outside clinical studies.
Yes, it helps regulate blood sugar, insulin, appetite, and energy expenditure, improving overall metabolism.
FDA and EMA approval is expected in the coming years, likely around 2026–2027.
Currently, it cannot be purchased – it is only available through clinical trials. Once approved, it will be available in pharmacies with a prescription.
Yes, once approved, it will only be available with a prescription under medical supervision.